Invesco Ltd. Checkpoint Therapeutics, Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$2.36 - $3.2 $66,934 - $90,758	-28,362 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.6 - $4.16 $8,507 - $13,611	3,272 Added 13.04%	28,362 $89,000
Q4 2020 Feb 16, 2021	BUY	$2.19 - $2.96 $54,947 - $74,266	25,090 New	25,090 $66,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $304M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.